Orthobiologics & Regenerative Medicine Series: Responsible Use of Orthobiologics in Sports Medicine: 2022 Update presented by Joanne Borg-Stein, MD-Responsible Use of Orthobiologics in Sports Medicine: 2022 Update

Video Transcription

Video Summary

In the video, Dr. Joanne Borgstein discusses responsible use of orthobiologics in sports medicine. She starts by introducing her role as an associate professor and medical director of regenerative sports medicine programs at various institutions. The goal of the webinars she hosts is to provide comprehensive education to physicians and reduce stigma and misinformation about regenerative medicine. The session includes an introduction to orthobiologics, the types of treatments available, and the potential benefits for conditions such as osteoarthritis and tendinopathy. Dr. Borgstein emphasizes the importance of safety, standardized protocols, and informed consent when delivering these treatments. She also discusses the need for comprehensive patient assessment, proficiency in image-guided procedures, and ongoing outcome measures to evaluate the effectiveness of the treatments. Dr. Borgstein highlights the importance of responsible advertising and adhering to regulatory guidelines to ensure patient safety. She mentions the establishment of a research infrastructure, including a biobank and a database to collect de-identified patient data for future research collaborations. Dr. Borgstein also touches on the need for ongoing education, training, and collaboration among clinicians, researchers, and industry to advance the field of orthobiologics in a responsible manner.

Keywords

orthobiologics

sports medicine

regenerative medicine

treatments

safety

patient assessment

outcome measures

research infrastructure

education

collaboration